1.
Kakugawa T,
Yokota S,
Ishimatsu Y,
Hayashi T,
Nakashima S,
Hara S,
Sakamoto N,
Matsuoka Y,
Kubota H,
Mine M,
Mukae H,
Nagata K,
Kohno S.
Serum heat shock protein 47 levels in patients with drug-induced lung disease.
Respir Res.
2013; 14(1): 133.
2.
Osamu Matsuno.
Drug-induced interstitial lung disease: mechanisms and best diagnostic approaches.
Respir Res.
2012; 13(1): 39.
3.
Sun Kim,
In-Jae Oh,
corresponding author,
Seo-Yeon Park,
Jang-Hyeon Song,
Hyun-Ju Seon,
Yun-Hyeon Kim,
Seong-Hoon Yoon,
Jin-Yeong Yu,
Bo-Ram Lee,
Kyu-Sik Kim and Young-Chul Kim.
Corticosteroid therapy against treatment-related pulmonary toxicities in patients with lung cancer.
J Thorac Dis.
2014 Sep; 6(9): 1209–1217.
4.
Santiago E.
Rossi,
Jeremy J.
Erasmus,
H.
Page McAdams,
Thomas A.
Sporn,
Philip C.
Goodman.
Pulmonary Drug Toxicity: Radiologic and Pathologic Manifestations.
RadioGraphics 2000; 20:1245–1259
5.
Jean M.
Torrisi,
Lawrence H.
Schwartz,
Marc J.
Gollub,
Michelle S.
Ginsberg,
George J.
Bosl,
and Hedvig Hricak.
CT Findings of Chemotherapyinduced Toxicity: What Radiologists Need to Know about the Clinical and Radiologic Manifestations of Chemotherapy Toxicity.
Radiology: Volume 258: Number 1—January 2011.
6.
Martin Schwaiblmair,
Werner Behr,
Thomas Haeckel,
Bruno Märkl,
Wolfgang Foerg and Thomas Berghaus.
Drug Induced Interstitial Lung Disease.
Open Respir Med J.
2012; 6: 63–74.
7.
Schwaiblmair M,
Behr W,
Haeckel T,
Markl B,
Foerg W,
Berghaus T.
Drug induced interstitial lung disease.
The open respiratory medicine journal 2012;6:63-74.
8.
Markos J,
Veronese ME,
Nicholson MR,
McLean S,
Shevland JE.
Value of hepatic computerized tomographic scanning during amiodarone therapy.
Am J Cardiol 1985;56:89-92.
